These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28370746)

  • 1. Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database.
    Raknes G; Småbrekke L
    Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):685-693. PubMed ID: 28370746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study.
    Raknes G; Småbrekke L
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):136-142. PubMed ID: 27670755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
    Raknes G; Småbrekke L
    PLoS One; 2019; 14(2):e0212460. PubMed ID: 30763385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Low-Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental Before-and-After Prescription Database Study.
    Raknes G; Simonsen P; Småbrekke L
    J Crohns Colitis; 2018 May; 12(6):677-686. PubMed ID: 29385430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing use of opioids from 2004 to 2007 - pharmacoepidemiological data from a complete national prescription database in Norway.
    Fredheim OM; Skurtveit S; Breivik H; Borchgrevink PC
    Eur J Pain; 2010 Mar; 14(3):289-94. PubMed ID: 19505834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid prescribing habits differ between Denmark, Sweden and Norway - and they change over time.
    Jarlbaek L
    Scand J Pain; 2019 Jul; 19(3):491-499. PubMed ID: 30817310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study.
    Raknes G; Småbrekke L
    BMC Endocr Disord; 2020 Oct; 20(1):151. PubMed ID: 33004044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription pattern of codeine for non-malignant pain: a pharmacoepidemiological study from the Norwegian Prescription Database.
    Fredheim OM; Skurtveit S; Moroz A; Breivik H; Borchgrevink PC
    Acta Anaesthesiol Scand; 2009 May; 53(5):627-33. PubMed ID: 19419357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To what extent does a cohort of new users of weak opioids develop persistent or probable problematic opioid use?
    Skurtveit S; Furu K; Borchgrevink P; Handal M; Fredheim O
    Pain; 2011 Jul; 152(7):1555-1561. PubMed ID: 21450405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study.
    Raknes G; Småbrekke L
    Sci Rep; 2019 Oct; 9(1):15085. PubMed ID: 31636347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics.
    Reset A; Skurtveit S; Furu K; Skovlund E
    Scand J Pain; 2018 Oct; 18(4):667-674. PubMed ID: 30145581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pharmacoepidemiological cohort study of subjects starting strong opioids for nonmalignant pain: a study from the Norwegian Prescription Database.
    Fredheim OMS; Borchgrevink PC; Mahic M; Skurtveit S
    Pain; 2013 Nov; 154(11):2487-2493. PubMed ID: 24075311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.
    Chang HY; Murimi I; Faul M; Rutkow L; Alexander GC
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):422-429. PubMed ID: 29488663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid prescription for terminally ill outpatients in a district of northern Italy: a retrospective survey.
    Salvato C; Aretini G; Serraglia D; Terrazzani G; Debetto P; Giusti P; Chinellato A
    Pharmacol Res; 2003 Jul; 48(1):75-82. PubMed ID: 12770518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A complete national cohort study of prescriptions of analgesics and benzodiazepines to cancer survivors in Norway 10 years after diagnosis.
    Fredheim OM; Skurtveit S; Handal M; Hjellvik V
    Pain; 2019 Apr; 160(4):852-859. PubMed ID: 30531310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013-2017): a prospective cohort study.
    Vold JH; Skurtveit S; Aas C; Johansson KA; Fadnes LT
    BMC Health Serv Res; 2020 Jul; 20(1):668. PubMed ID: 32690022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The duration and course of opioid therapy in patients with chronic non-malignant pain.
    Mellbye A; Karlstad Ø; Skurtveit S; Borchgrevink PC; Fredheim OM
    Acta Anaesthesiol Scand; 2016 Jan; 60(1):128-37. PubMed ID: 26242816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in opioid consumption in the Nordic countries 2002-2006.
    Hamunen K; Paakkari P; Kalso E
    Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway.
    Fredheim OM; Log T; Olsen W; Skurtveit S; Sagen Ø; Borchgrevink PC
    Paediatr Anaesth; 2010 Jun; 20(6):537-44. PubMed ID: 20609118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Low dose naltrexone for treatment of pain].
    Plesner KB; Vægter HB; Handberg G
    Ugeskr Laeger; 2015 Oct; 177(43):V03150248. PubMed ID: 26509454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.